Roubaix Capital, LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 113 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Roubaix Capital, LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2019$2,094,000
-22.3%
39,117
-13.3%
1.91%
-15.3%
Q2 2019$2,695,00045,1422.25%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 211,370$9,833,0005.80%
JW Asset Management, LLC 73,649$3,426,0002.51%
NORTHPOINTE CAPITAL LLC 135,657$6,311,0000.67%
Elk Creek Partners, LLC 170,102$7,913,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 156,167$7,265,0000.32%
Ativo Capital Management LLC 22,592$1,051,0000.28%
Matarin Capital Management, LLC 59,077$2,748,262,0000.23%
ISTHMUS PARTNERS, LLC 16,753$779,0000.22%
CADENCE CAPITAL MANAGEMENT LLC 29,586$1,376,0000.09%
ALGERT GLOBAL LLC 7,834$364,0000.08%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders